$SEPN

Biotech Firm Septerna Soars With Novo Nordisk In A $2.2 Billion Obesity And Diabetes Deal

$SEPN In a significant development in the pharmaceutical industry, Septerna (NASDAQ:SEPN) has entered into a groundbreaking $2.2 billion collaboration with…